{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T13:53:52Z","timestamp":1770818032957,"version":"3.50.1"},"reference-count":32,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,2,24]],"date-time":"2023-02-24T00:00:00Z","timestamp":1677196800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["celltherapyjournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytotherapy"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1016\/j.jcyt.2023.02.010","type":"journal-article","created":{"date-parts":[[2023,3,21]],"date-time":"2023-03-21T08:38:10Z","timestamp":1679387890000},"page":"598-604","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Reference gene selection for clinical chimeric antigen receptor T-cell product vector copy number assays"],"prefix":"10.1016","volume":"25","author":[{"given":"Jinxia","family":"Ma","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3009-7096","authenticated-orcid":false,"given":"Lipei","family":"Shao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatyana","family":"Fuksenko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rongye","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anh","family":"Dinh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven L.","family":"Highfill","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandhya R.","family":"Panch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert P.","family":"Somerville","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David F.","family":"Stroncek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ping","family":"Jin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcyt.2023.02.010_bib0001","doi-asserted-by":"crossref","first-page":"385","DOI":"10.3109\/10428199509059636","article-title":"CD19 antigen in leukemia and lymphoma diagnosis and immunotherapy","volume":"18","author":"Scheuermann","year":"1995","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.jcyt.2023.02.010_bib0002","doi-asserted-by":"crossref","first-page":"4099","DOI":"10.1182\/blood-2010-04-281931","article-title":"Eradication of B-lineage cells and regression of lymphoma in a patient treated with autologous T cells genetically engineered to recognize CD19","volume":"116","author":"Kochenderfer","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.jcyt.2023.02.010_bib0003","doi-asserted-by":"crossref","first-page":"3539","DOI":"10.1182\/bloodadvances.2019000692","article-title":"CAR T-cell therapy is effective for CD19-dim B-lymphoblastic leukemia but is impacted by prior blinatumomab therapy","volume":"3","author":"Pillai","year":"2019","journal-title":"Blood Advances"},{"key":"10.1016\/j.jcyt.2023.02.010_bib0004","first-page":"5","article-title":"CD19-targeted CAR regulatory T cells suppress B cell pathology without GvHD","author":"Imura","year":"2020","journal-title":"JCI Insight"},{"key":"10.1016\/j.jcyt.2023.02.010_bib0005","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1097\/CJI.0b013e318194a6e8","article-title":"Manufacturing validation of biologically functional T cells targeted to CD19 antigen for autologous adoptive cell therapy","volume":"32","author":"Hollyman","year":"2009","journal-title":"J Immunother"},{"key":"10.1016\/j.jcyt.2023.02.010_bib0006","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1089\/hgtb.2017.078","article-title":"Development of the first World Health Organization lentiviral vector standard: toward the production control and standardization of lentivirus-based gene therapy products","volume":"28","author":"Zhao","year":"2017","journal-title":"Hum Gene Ther Methods"},{"key":"10.1016\/j.jcyt.2023.02.010_bib0007","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1177\/2472630317705680","article-title":"Digital assays part I: partitioning statistics and digital PCR","volume":"22","author":"Basu","year":"2017","journal-title":"SLAS Technol"},{"key":"10.1016\/j.jcyt.2023.02.010_bib0008","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1021\/ac202578x","article-title":"Evaluation of a droplet digital polymerase chain reaction format for DNA copy number quantification","volume":"84","author":"Pinheiro","year":"2012","journal-title":"Anal Chem"},{"key":"10.1016\/j.jcyt.2023.02.010_bib0009","doi-asserted-by":"crossref","first-page":"8604","DOI":"10.1021\/ac202028g","article-title":"High-throughput droplet digital PCR system for absolute quantitation of DNA copy number","volume":"83","author":"Hindson","year":"2011","journal-title":"Anal Chem"},{"key":"10.1016\/j.jcyt.2023.02.010_bib0010","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1186\/s12967-020-02358-0","article-title":"Application of droplet digital PCR for the detection of vector copy number in clinical CAR\/TCR T cell products","volume":"18","author":"Lu","year":"2020","journal-title":"J Transl Med"},{"key":"10.1016\/j.jcyt.2023.02.010_bib0011","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.jmoldx.2020.02.007","article-title":"Detection and quantification of chimeric antigen receptor transgene copy number by droplet digital PCR versus real-time PCR","volume":"22","author":"Lou","year":"2020","journal-title":"J Mol Diagn"},{"key":"10.1016\/j.jcyt.2023.02.010_bib0012","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1186\/s12967-021-02925-z","article-title":"Droplet digital PCR allows vector copy number assessment and monitoring of experimental CAR T cells in murine xenograft models or approved CD19 CAR T cell-treated patients","volume":"19","author":"Haderbache","year":"2021","journal-title":"J Transl Med"},{"key":"10.1016\/j.jcyt.2023.02.010_bib0013","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1097\/CCO.0b013e328333dca4","article-title":"Copy number variations and cancer susceptibility","volume":"22","author":"Shlien","year":"2010","journal-title":"Curr Opin Oncol"},{"key":"10.1016\/j.jcyt.2023.02.010_bib0014","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/gm62","article-title":"Copy number variations and cancer","volume":"1","author":"Shlien","year":"2009","journal-title":"Genome Med"},{"key":"10.1016\/j.jcyt.2023.02.010_bib0015","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1038\/nrclinonc.2017.198","article-title":"Determinants and clinical implications of chromosomal instability in cancer","volume":"15","author":"Sansregret","year":"2018","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.jcyt.2023.02.010_bib0016","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1146\/annurev-med-100708-204735","article-title":"Structural variation in the human genome and its role in disease","volume":"61","author":"Stankiewicz","year":"2010","journal-title":"Annu Rev Med"},{"key":"10.1016\/j.jcyt.2023.02.010_bib0017","doi-asserted-by":"crossref","first-page":"R41","DOI":"10.1186\/gb-2011-12-4-r41","article-title":"GISTIC2.0 facilitates sensitive and confident localization of the targets of focal somatic copy-number alteration in human cancers","volume":"12","author":"Mermel","year":"2011","journal-title":"Genome Biol"},{"key":"10.1016\/j.jcyt.2023.02.010_bib0018","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1182\/blood-2016-04-711903","article-title":"T cells expressing an anti-B-cell maturation antigen chimeric antigen receptor cause remissions of multiple myeloma","volume":"128","author":"Ali","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.jcyt.2023.02.010_bib0019","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/j.jcyt.2016.04.003","article-title":"Myeloid cells in peripheral blood mononuclear cell concentrates inhibit the expansion of chimeric antigen receptor T cells","volume":"18","author":"Stroncek","year":"2016","journal-title":"Cytotherapy"},{"key":"10.1016\/j.jcyt.2023.02.010_bib0020","first-page":"16","article-title":"Enhanced clinical-scale manufacturing of TCR transduced T-cells using closed culture system modules","author":"Jin","year":"2018","journal-title":"Journal of Translational Medicine"},{"key":"10.1016\/j.jcyt.2023.02.010_bib0021","doi-asserted-by":"crossref","first-page":"2759-+","DOI":"10.1200\/JCO.18.02424","article-title":"T-cell receptor gene therapy for human papillomavirus-associated epithelial cancers: a first-in-human, phase I\/II study","volume":"37","author":"Doran","year":"2019","journal-title":"Journal of Clinical Oncology"},{"key":"10.1016\/j.jcyt.2023.02.010_bib0022","article-title":"Digital droplet PCR: CNV analysis and other applications","volume":"82","author":"Mazaika","year":"2014","journal-title":"Curr Protoc Hum Genet"},{"key":"10.1016\/j.jcyt.2023.02.010_bib0023","article-title":"Dropulic: persistent polyfunctional chimeric antigen receptor T cells that target glypican 3 eliminate orthotopic hepatocellular carcinomas in mice (vol 158, 2250, 2020)","volume":"160","author":"Li","year":"2021","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jcyt.2023.02.010_bib0024","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1038\/ejhg.2016.56","article-title":"Digital PCR for discriminating mosaic deletions and for determining proportion of tumor cells in specimen","volume":"24","author":"Kluwe","year":"2016","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/j.jcyt.2023.02.010_bib0025","doi-asserted-by":"crossref","first-page":"198","DOI":"10.5582\/irdr.2019.01067","article-title":"Advantages of ddPCR in detection of PLP1 duplications","volume":"8","author":"Imaizumi","year":"2019","journal-title":"Intractable Rare Dis Res"},{"key":"10.1016\/j.jcyt.2023.02.010_bib0026","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1007\/s40291-021-00546-2","article-title":"Development and evaluation of a droplet digital PCR assay for 8p23 beta-defensin cluster copy number determination","volume":"25","author":"Wen","year":"2021","journal-title":"Mol Diagn Ther"},{"key":"10.1016\/j.jcyt.2023.02.010_bib0027","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/S0145-2126(00)00125-9","article-title":"Complete karyotype characterization of the K562 cell line by combined application of G-banding, multiplex-fluorescence in situ hybridization, fluorescence in situ hybridization, and comparative genomic hybridization","volume":"25","author":"Naumann","year":"2001","journal-title":"Leuk Res"},{"key":"10.1016\/j.jcyt.2023.02.010_bib0028","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1038\/sj.bjc.6601569","article-title":"Chromosomal analysis of non-small-cell lung cancer by multicolour fluorescent in situ hybridisation","volume":"90","author":"Berrieman","year":"2004","journal-title":"Br J Cancer"},{"key":"10.1016\/j.jcyt.2023.02.010_bib0029","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cancergencyto.2005.03.007","article-title":"Chromosome abnormalities in 10 lung cancer cell lines of the NCI-H series analyzed with spectral karyotyping","volume":"162","author":"Grigorova","year":"2005","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/j.jcyt.2023.02.010_bib0030","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1053\/jhep.2000.19349","article-title":"A comprehensive karyotypic study on human hepatocellular carcinoma by spectral karyotyping","volume":"32","author":"Wong","year":"2000","journal-title":"Hepatology"},{"key":"10.1016\/j.jcyt.2023.02.010_bib0031","doi-asserted-by":"crossref","first-page":"5581","DOI":"10.1038\/sj.onc.1209537","article-title":"Molecular karyotyping of human hepatocellular carcinoma using single-nucleotide polymorphism arrays","volume":"25","author":"Midorikawa","year":"2006","journal-title":"Oncogene"},{"key":"10.1016\/j.jcyt.2023.02.010_bib0032","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s13073-021-00852-8","article-title":"Clinical-grade whole-genome sequencing and 3\u2032 transcriptome analysis of colorectal cancer patients","volume":"13","author":"Stodolna","year":"2021","journal-title":"Genome Med"}],"container-title":["Cytotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1465324923000622?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1465324923000622?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T01:50:43Z","timestamp":1761443443000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1465324923000622"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":32,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,6]]}},"alternative-id":["S1465324923000622"],"URL":"https:\/\/doi.org\/10.1016\/j.jcyt.2023.02.010","relation":{},"ISSN":["1465-3249"],"issn-type":[{"value":"1465-3249","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Reference gene selection for clinical chimeric antigen receptor T-cell product vector copy number assays","name":"articletitle","label":"Article Title"},{"value":"Cytotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcyt.2023.02.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc. on behalf of International Society for Cell & Gene Therapy.","name":"copyright","label":"Copyright"}]}}